Literature DB >> 23222548

Sex differences in rising trends of cutaneous malignant melanoma in Norway, 1954-2008.

Trude E Robsahm1, Gjøril Bergva, Unn E Hestvik, Bjørn Møller.   

Abstract

With more than a seven-fold increase during the last 50 years, the incidence rate of cutaneous malignant melanoma in Norway is amongst the highest worldwide. The present study aims to present the incidence trends of cutaneous malignant melanoma in Norway, 1954-2008, according to period, sex, age, stage of disease, anatomical location and geographical regions, and discuss the results in relation to sun exposure habits over time. All new cases of invasive cutaneous malignant melanoma diagnosed in the Norwegian population between 1 January 1954 and 31 December 2008 were retrieved from the Cancer Registry of Norway (n=31 783). In addition to descriptive analyses, joinpoint and age-period-cohort regression models were used to explore the incidence trends. Throughout the 1980s, a steep increase in the rate of melanoma was observed in both sexes, continuing to increase from the late 1990s. Age-specific incidence rates showed the steepest increase in age groups older than 50 years, and were most pronounced in men. A clear sex-specific anatomical distribution exists, although the trunk has become the most common location for both sexes. During the entire period of follow-up, a two-fold risk was observed in inhabitants of the southern compared with the northern part of Norway. It is reasonable to suggest that the rising incidence rates of melanoma in Norway, in both sexes, reflect a strengthened intermittent sun exposure pattern over time. The particularly strong incidence increase in older men corresponds with their less favourable sun-protective behaviour.

Entities:  

Mesh:

Year:  2013        PMID: 23222548     DOI: 10.1097/CMR.0b013e32835c7e48

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  11 in total

1.  Cutaneous squamous cell carcinoma in Norway 1963-2011: increasing incidence and stable mortality.

Authors:  Trude E Robsahm; Per Helsing; Marit B Veierød
Journal:  Cancer Med       Date:  2015-01-26       Impact factor: 4.452

2.  A protocol for prospective studies of 25-hydroxyvitamin D, leptin and body mass index in relation to cutaneous melanoma incidence and survival.

Authors:  Jo Steinson Stenehjem; Tom K Grimsrud; Judith R Rees; Linda Vos; Ronnie Babigumira; Marit B Veierød; Trude Eid Robsahm
Journal:  BMJ Open       Date:  2017-06-21       Impact factor: 2.692

3.  High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry.

Authors:  Trude Eid Robsahm; Per Helsing; Yngvar Nilssen; Linda Vos; Syed Mohammad H Rizvi; Lars A Akslen; Marit B Veierød
Journal:  Clin Epidemiol       Date:  2018-05-09       Impact factor: 4.790

4.  Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.

Authors:  Elizabeth Ann L Enninga; Justin C Moser; Amy L Weaver; Svetomir N Markovic; Jerry D Brewer; Alexey A Leontovich; Tina J Hieken; Lynne Shuster; Lisa A Kottschade; Ariadna Olariu; Aaron S Mansfield; Roxana S Dronca
Journal:  Cancer Med       Date:  2017-09-06       Impact factor: 4.452

5.  A four-DNA methylation biomarker is a superior predictor of survival of patients with cutaneous melanoma.

Authors:  Wenna Guo; Liucun Zhu; Rui Zhu; Qihan Chen; Qiang Wang; Jian-Qun Chen
Journal:  Elife       Date:  2019-06-06       Impact factor: 8.140

6.  Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy.

Authors:  Juliette Varin; Margaret M Reynolds; Nassima Bouzidi; Sarah Tick; Juliette Wohlschlegel; Ondine Becquart; Christelle Michiels; Olivier Dereure; Robert M Duvoisin; Catherine W Morgans; José-Alain Sahel; Quentin Samaran; Bernard Guillot; José S Pulido; Isabelle Audo; Christina Zeitz
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

7.  Trends in Incidence and Mortality of Skin Melanoma in Lithuania 1991-2015.

Authors:  Audrius Dulskas; Dovile Cerkauskaite; Ieva Vincerževskiene; Vincas Urbonas
Journal:  Int J Environ Res Public Health       Date:  2021-04-15       Impact factor: 3.390

8.  New malignancies after squamous cell carcinoma and melanomas: a population-based study from Norway.

Authors:  Trude E Robsahm; Margaret R Karagas; Judy R Rees; Astri Syse
Journal:  BMC Cancer       Date:  2014-03-19       Impact factor: 4.430

Review 9.  Estrogen Receptors and Melanoma: A Review.

Authors:  Emi Dika; Annalisa Patrizi; Martina Lambertini; Nicholas Manuelpillai; Michelangelo Fiorentino; Annalisa Altimari; Manuela Ferracin; Mattia Lauriola; Enrica Fabbri; Elena Campione; Giulia Veronesi; Federica Scarfì
Journal:  Cells       Date:  2019-11-19       Impact factor: 6.600

10.  Prediagnostic serum 25-hydroxyvitamin D and melanoma risk.

Authors:  Jo S Stenehjem; Nathalie C Støer; Reza Ghiasvand; Tom K Grimsrud; Ronnie Babigumira; Judy R Rees; Lill Tove Nilsen; Bjørn Johnsen; Per M Thorsby; Marit B Veierød; Trude E Robsahm
Journal:  Sci Rep       Date:  2020-11-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.